Sheena C. Tenney

Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma

Julie R. Park, Susan G. Kreissman, Wendy B. London et al. · JAMA · 2019 · 357 citations · Full text

Medicine, Immunology, Oncology +14

Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032

Alice L. Yu, Andrew L. Gilman, M. Fevzi Özkaynak et al. · Clinical Cancer Research · 2021 · 216 citations · Full text

Life Sciences, Immunology, Oncology +17

Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children’s Oncology Group Study ANBL0531

Clare J. Twist, Mary Lou Schmidt, Arlene Naranjo et al. · Journal of Clinical Oncology · 2019 · 128 citations · Full text

Medicine, Oncology, Pediatrics +16

A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children’s Oncology Group Study ANBL0931

M. Fevzi Özkaynak, Andrew L. Gilman, Wendy B. London et al. · Frontiers in Immunology · 2018 · 91 citations · Full text

Pharmacy, Oncology, Pharmacology +17

A phase III randomized clinical trial (RCT) of tandem myeloablative autologous stem cell transplant (ASCT) using peripheral blood stem cell (PBSC) as consolidation therapy for high-risk neuroblastoma (HR-NB): A Children's Oncology Group (COG) study.

Julie R. Park, Susan G. Kreissman, Wendy B. London et al. · Journal of Clinical Oncology · 2016 · 64 citations

Medicine, Oncology, Cell Therapy +9